268 related articles for article (PubMed ID: 19204649)
21. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
Szarfman A; Machado SG; O'Neill RT
Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
[TBL] [Abstract][Full Text] [Related]
22. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
23. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
[TBL] [Abstract][Full Text] [Related]
25. Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
Brown J; Aitken SL; van Manen RP
Pharmacotherapy; 2011 Jun; 31(6):585-90. PubMed ID: 21923442
[TBL] [Abstract][Full Text] [Related]
26. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
[TBL] [Abstract][Full Text] [Related]
27. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo.
Klemp M; Tvete IF; Skomedal T; Gaasemyr J; Natvig B; Aursnes I
J Clin Psychopharmacol; 2011 Dec; 31(6):698-704. PubMed ID: 22020356
[TBL] [Abstract][Full Text] [Related]
28. The association between class of antipsychotic and rates of hospitalization: results of a retrospective analysis of data from the 2005 Medicare current beneficiary survey.
Kennedy J; Tien YY; Cohen LJ; Sclar DA; Liu D; Blodgett EG; Engle J
Clin Ther; 2009 Dec; 31(12):2931-9. PubMed ID: 20110033
[TBL] [Abstract][Full Text] [Related]
29. Abnormal glucose metabolism in patients treated with antipsychotics.
Scheen AJ; De Hert MA
Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
[TBL] [Abstract][Full Text] [Related]
30. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
Rivkees SA; Szarfman A
J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
[TBL] [Abstract][Full Text] [Related]
31. Antipsychotics and diabetes: an age-related association.
Hammerman A; Dreiher J; Klang SH; Munitz H; Cohen AD; Goldfracht M
Ann Pharmacother; 2008 Sep; 42(9):1316-22. PubMed ID: 18664607
[TBL] [Abstract][Full Text] [Related]
32. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
Hauben M; Reich L; Gerrits CM
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
[TBL] [Abstract][Full Text] [Related]
33. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
34. A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia.
Juba KM; van Manen RP; Fellows SE
Ann Pharmacother; 2020 Mar; 54(3):247-253. PubMed ID: 31648533
[No Abstract] [Full Text] [Related]
35. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
Hauben M; Horn S; Reich L
Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
[TBL] [Abstract][Full Text] [Related]
36. Comparing data mining methods on the VAERS database.
Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
[TBL] [Abstract][Full Text] [Related]
37. Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.
Gianfrancesco F; Pesa J; Wang RH; Nasrallah H
Am J Health Syst Pharm; 2006 Mar; 63(5):431-41. PubMed ID: 16484517
[TBL] [Abstract][Full Text] [Related]
38. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
[TBL] [Abstract][Full Text] [Related]
39. Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations.
Sagreiya H; Chen YR; Kumarasamy NA; Ponnusamy K; Chen D; Das AK
Cureus; 2017 Feb; 9(2):e1059. PubMed ID: 28465867
[TBL] [Abstract][Full Text] [Related]
40. The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
Yood MU; DeLorenze G; Quesenberry CP; Oliveria SA; Tsai AL; Willey VJ; McQuade R; Newcomer J; L'Italien G
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):791-9. PubMed ID: 19526626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
